Advertisement

Loading...

OrganiGram Holdings Inc.

OGI.TOTSX
Healthcare
Drug Manufacturers - Specialty & Generic
$1.88
$0.03(1.62%)
Canadian Market opens in 14h 55m

OrganiGram Holdings Inc. Fundamental Analysis

OrganiGram Holdings Inc. (OGI.TO) shows moderate financial fundamentals with a PE ratio of 13.81, profit margin of 6.49%, and ROE of 4.86%. The company generates $0.3B in annual revenue with strong year-over-year growth of 62.15%.

Key Strengths

PEG Ratio0.08
Current Ratio2.73

Areas of Concern

ROE4.86%
Operating Margin-28.72%
Cash Position3.30%
We analyze OGI.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 59.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
59.1/100

We analyze OGI.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

OGI.TO struggles to generate sufficient returns from assets.

ROA > 10%
3.42%

Valuation Score

Excellent

OGI.TO trades at attractive valuation levels.

PE < 25
13.81
PEG Ratio < 2
0.08

Growth Score

Excellent

OGI.TO delivers strong and consistent growth momentum.

Revenue Growth > 5%
62.15%
EPS Growth > 10%
60.42%

Financial Health Score

Excellent

OGI.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.02
Current Ratio > 1
2.73

Profitability Score

Weak

OGI.TO struggles to sustain strong margins.

ROE > 15%
4.86%
Net Margin ≥ 15%
6.49%
Positive Free Cash Flow
No

Key Financial Metrics

Is OGI.TO Expensive or Cheap?

P/E Ratio

OGI.TO trades at 13.81 times earnings. This suggests potential undervaluation.

13.81

PEG Ratio

When adjusting for growth, OGI.TO's PEG of 0.08 indicates potential undervaluation.

0.08

Price to Book

The market values OrganiGram Holdings Inc. at 0.68 times its book value. This may indicate undervaluation.

0.68

EV/EBITDA

Enterprise value stands at -16.22 times EBITDA. This is generally considered low.

-16.22

How Well Does OGI.TO Make Money?

Net Profit Margin

For every $100 in sales, OrganiGram Holdings Inc. keeps $6.49 as profit after all expenses.

6.49%

Operating Margin

Core operations generate -28.72 in profit for every $100 in revenue, before interest and taxes.

-28.72%

ROE

Management delivers $4.86 in profit for every $100 of shareholder equity.

4.86%

ROA

OrganiGram Holdings Inc. generates $3.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.42%

Following the Money - Real Cash Generation

Operating Cash Flow

OrganiGram Holdings Inc. generates limited operating cash flow of $-19.49M, signaling weaker underlying cash strength.

$-19.49M

Free Cash Flow

OrganiGram Holdings Inc. generates weak or negative free cash flow of $-37.19M, restricting financial flexibility.

$-37.19M

FCF Per Share

Each share generates $-0.27 in free cash annually.

$-0.27

FCF Yield

OGI.TO converts -14.44% of its market value into free cash.

-14.44%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

13.81

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.68

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.91

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.73

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.05

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.18

vs 25 benchmark

How OGI.TO Stacks Against Its Sector Peers

MetricOGI.TO ValueSector AveragePerformance
P/E Ratio13.8128.31 Better (Cheaper)
ROE4.86%699.00% Weak
Net Margin6.49%-131318.00% (disorted) Weak
Debt/Equity0.020.34 Strong (Low Leverage)
Current Ratio2.732775.16 Strong Liquidity
ROA3.42%-14513.00% (disorted) Weak

OGI.TO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews OrganiGram Holdings Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.96%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

93.85%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

94.31%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ